C-MER Medical Holdings (HKSE:03309) Beneish M-Score: -2.66 (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03309 C-MER Medical Holdings Ltd HKSE:03309
83 GF Score
Price HK$0.86
GF Value HK$2.77
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is C-MER Medical Holdings Beneish M-Score?

C-MER Medical Holdings HKSE:03309 -0.58% 83 Beneish M-Score is -2.66 as of Aug. 29, 2026. GuruFocus rates HKSE:03309 with a GF Score™ of 83/100 and a GF Value™ of HK$2.77 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 629 Healthcare Providers & Services companies, C-MER Medical Holdings ranks better than 55.01% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.66 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for C-MER Medical Holdings's Beneish M-Score or its related term are showing as below:

HKSE:03309' s Beneish M-Score Range Over the Past 10 Years
Min: -3.55   Med: -2.46   Max: 0.56
Current: -2.66

During the past 12 years, the highest Beneish M-Score of C-MER Medical Holdings was 0.56. The lowest was -3.55. And the median was -2.46.


C-MER Medical Holdings Beneish M-Score Historical Data

* Premium members only.

The historical data trend for C-MER Medical Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

C-MER Medical Holdings Beneish M-Score Chart

C-MER Medical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.26 -1.86 -2.78 -3.10 -2.66

C-MER Medical Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.78 0.00 -3.10 0.00 -2.66

HKSE:03309 vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, C-MER Medical Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-MER Medical Holdings Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, C-MER Medical Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where C-MER Medical Holdings's Beneish M-Score falls into.


HKSE:03309
83GF Score
C-MER Medical Holdings Ltd HKSE:03309
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

C-MER Medical Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of C-MER Medical Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1447+0.528 * 0.8893+0.404 * 0.9645+0.892 * 1.0175+0.115 * 1.4946
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9733+4.679 * -0.066941-0.327 * 1.0168
=-2.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was HK$93 Mil.
Revenue was HK$1,947 Mil.
Gross Profit was HK$604 Mil.
Total Current Assets was HK$671 Mil.
Total Assets was HK$2,733 Mil.
Property, Plant and Equipment(Net PPE) was HK$741 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$199 Mil.
Selling, General, & Admin. Expense(SGA) was HK$471 Mil.
Total Current Liabilities was HK$468 Mil.
Long-Term Debt & Capital Lease Obligation was HK$256 Mil.
Net Income was HK$100 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$283 Mil.
Total Receivables was HK$80 Mil.
Revenue was HK$1,913 Mil.
Gross Profit was HK$528 Mil.
Total Current Assets was HK$640 Mil.
Total Assets was HK$2,720 Mil.
Property, Plant and Equipment(Net PPE) was HK$717 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$331 Mil.
Selling, General, & Admin. Expense(SGA) was HK$476 Mil.
Total Current Liabilities was HK$410 Mil.
Long-Term Debt & Capital Lease Obligation was HK$299 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(93.058 / 1946.712) / (79.891 / 1913.162)
=0.047803 / 0.041759
=1.1447

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(527.619 / 1913.162) / (603.67 / 1946.712)
=0.275784 / 0.310097
=0.8893

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (671.39 + 741.136) / 2732.626) / (1 - (640.475 + 717.271) / 2720.152)
=0.483088 / 0.500857
=0.9645

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1946.712 / 1913.162
=1.0175

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(331.476 / (331.476 + 717.271)) / (198.763 / (198.763 + 741.136))
=0.316069 / 0.211473
=1.4946

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(471.382 / 1946.712) / (475.975 / 1913.162)
=0.242143 / 0.24879
=0.9733

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((255.55 + 468.394) / 2732.626) / ((298.69 + 410.022) / 2720.152)
=0.264926 / 0.260541
=1.0168

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(100.366 - 0 - 283.292) / 2732.626
=-0.066941

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

C-MER Medical Holdings has a M-score of -2.66 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.66 mean?
C-MER Medical Holdings (HKSE:03309) has a Beneish M-Score of -2.66 as of Aug. 29, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on C-MER Medical Holdings and its competitors. According to the industry distribution chart, C-MER Medical Holdings ranks #283 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 45%.
Is C-MER Medical Holdings' Beneish M-Score too high?
C-MER Medical Holdings' current Beneish M-Score is -2.66. Based on the distribution chart, C-MER Medical Holdings ranks #283 out of 629 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, C-MER Medical Holdings has a GF Score™ of 83/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does C-MER Medical Holdings' Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, C-MER Medical Holdings ranks #283 out of 629 companies for Beneish M-Score. This puts C-MER Medical Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on C-MER Medical Holdings and its competitors. C-MER Medical Holdings's current Beneish M-Score is -2.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C-MER Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, C-MER Medical Holdings (HKSE:03309) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.77, compared to a current price of HK$0.86 — trading 69.1% below its estimated fair value. The current Beneish M-Score is -2.66. C-MER Medical Holdings' overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For C-MER Medical Holdings (HKSE:03309), the current Beneish M-Score is -2.66 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is C-MER Medical Holdings (HKSE:03309) Overvalued in 2026?

Based on GuruFocus' analysis, C-MER Medical Holdings stock appears to be undervalued. The current stock price of HK$0.86 is trading 69.1% below its estimated GF Value™ of HK$2.77. GuruFocus considers C-MER Medical Holdings to be Possible Value Trap.

Key valuation signals for HKSE:03309:

  • Beneish M-Score: -2.66
  • GF Value™: HK$2.77 vs. price of HK$0.86 (69.1% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the HKSE:03309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


C-MER Medical Holdings Business Description

Address 1-3 Pedder Street, Room 1535, China Construction Building, Central, Hong Kong, HKG
C-MER Medical Holdings Ltd is a ophthalmic medical chain group in Hong Kong and the Greater Bay Area. With ophthalmology as its core, it has gradually expanded its business scope to different specialist services. The company through its subsidiaries are principally engaged in the provision of ophthalmic, dental and other medical services, sales of vision aid products and sales of medical consumables in Hong Kong and Mainland China. Geographically, the company generates revenue from Mailand China, and Hong Kong, with the majority of revenue generated from Mainland China.
83GF Score

Get the complete analysis for HKSE:03309

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.86
Price
HK$2.77
GF Value